Advertisement Global Med's blood management software receives FDA clearance - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Global Med’s blood management software receives FDA clearance

Global Med Technologies has announced that the FDA has granted 510(k) clearance for ElDorado Donor, a new blood management product produced by its Wyndgate Technologies division, paving the way for the company to proceed marketing the product in the US.

The ElDorado Donor release is the company’s next generation software and is intended as a comprehensive blood management software application created to provide for the information system needs of blood bank and donor centers. The software is designed to manage, automate, and control activities associated with donors, donor collections, testing, manufacturing, inventory, and distribution. The release is said to mark a new growth opportunity for the company both domestically and internationally. ElDorado Donor is designed to support the industry standard for labeling (ISBT128), as well as the ABC Codabar blood product labeling standard.

Thomas Marcinek, president and COO of Global Med Technologies, said: ” We believe that the introduction of ElDorado Donor brings us closer to our goal of becoming the world leader in blood management software and services.”